THThe Hindu·2hHealth
score-0.30
NPPA Cuts Prices on 543 Cancer Brands; Experts Argue Affordability Must Rest on Medical Need
Original
Sharp cuts in price of cancer drugs expose excessive pricing, say health experts
“Highlights excessive pricing and systemic failures in cancer drug access while noting government regulatory action.”